Powered by: Motilal Oswal
05-11-2024 01:01 PM | Source: Nirmal Bang Ltd.
IPO Note : Sagility Ltd by Nirmal Bang Ltd

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

BACKGROUND

Sagility is a pure healthcare focused technology driven service provider having client profile of Payers which include leading U.S. health insurance companies and Providers including hospitals, physicians, and diagnostic and medical devices Company’s amongst others. 90% of the company’s revenues come from the payers segment where it is involved in the core benefit admin functions deriving predictable revenues. It operates through five global service delivery locations present in India, the Philippines, the U.S., Jamaica and Colombia.

Sagility holds deep domain expertise and leadership position in the focused payer healthcare market offering comprehensive services as against the other traditional IT players. With growing outsourcing outlook of the traditionally conservative Healthcare industry, Sagility holds a better position to gain traction and gain market share. Shares are available at an adjusted P/E of 24x and EV/EBIDTA of 13x FY24 earnings which seems reasonable given its highly focused nature of business and thus recommend ‘Subscribe’ to the issue.

Details of the Issue:

IPO is a book-building issue worth Rs. 2,106.6 crore comprising only an offerfor-sale (OFS) of 70.22 crore shares.

Objects of the Issue:

To list on the stock exchange.

Investment Rationale:

1. Leader in large US Healthcare Payer and Provide Market.

2. Deep Domain Expertise enabling end to end service offerings.

3. Strategic Advantages with strong Promoter background.

4. Stable and Good Financial Performance with good set of margins.

 

Please refer disclaimer at https://www.nirmalbang.com/disclaimer.aspx
SEBI Registration number is INH000001766

 

 

To Read Complete Report & Disclaimer     Click Here

Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer